A novel PI3K inhibitor alleviates fibrotic respo... [Int J Oncol. 2013] - PubMed - NCBI (http://www.ncbi.nlm.nih.gov/pubmed/23588860)
Another interesting read concerning our condition.
Thank you for the link.
I just don't understand the "In this study" mentioned as no quantitative and/or qualitative data is available.
James
if you look at the bottom James, it says
"PubMed - in process"
PubMed In Process records provide basic citation information and abstracts while these records are reviewed for accuracy of the bibliographic data and assigned subject headings if the subject of the article is within the scope of MEDLINE.
New records are generally added Tuesday through Saturday. In Process records carry the status tag [PubMed - in process].
Each In Process record has a PMID.
After MeSH terms, publication types, and other indexing data are added, the citations graduate to MEDLINE records.
So, in essence , it seems to be in progress and review, and there should be data eventually I'm assuming. I'd like to see it as well trust me.
PI3K inhibitors, as well as ALK5 Inhibitors, showed reduction on Peyronies Disease fibrosis.
Sooner or Later I will buy this stuff and try it on myself.
My problem with "in process" is that it is not an indication about when it will be available. It is months, years, decades, centuries?
But it is important to post regarding the subject, at least we know that someone is doing something that may help us and we can do a follow up.
James
yyy how will you buy it? And if you somehow do, how would you go about administering it?